Palantir Q1 2026 Earnings EPS Surpasses Estimates Revenue Details Unavailable Stock Edges Lower
MED Q1 2026 Earnings NarrowerThanExpected Loss Signals Operational Resilience
SHC Q1 2026 Earnings EPS Surpasses Estimates Despite Stock Pullback
CBFV Q1 2026 Earnings EPS Beats Estimates Stock Rises on Strong Performance
Metallus MTUS Q1 2026 Earnings EPS Beat Highlights Cost Discipline Amid Revenue Headwinds
Syndax Pharmaceuticals Q1 2026 Earnings Narrowed Loss Beats Estimates as Pipeline Progress Continues